Literature DB >> 23870850

Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.

K Eichelmann1, S E González González, J C Salas-Alanis, J Ocampo-Candiani.   

Abstract

Leprosy is a chronic granulomatous disease caused by the bacillus Mycobacterium leprae. It primarily affects the skin and peripheral nerves and is still endemic in various regions of the world. Clinical presentation depends on the patient's immune status at the time of infection and during the course of the disease. Leprosy is associated with disability and marginalization. Diagnosis is clinical and is made when the patient has at least 1 of the following cardinal signs specified by the World Health Organization: hypopigmented or erythematous macules with sensory loss; thickened peripheral nerves; or positive acid-fast skin smear or skin biopsy with loss of adnexa at affected sites. Leprosy is treated with a multidrug combination of rifampicin, clofazimine, and dapsone. Two main regimens are used depending on whether the patient has paucibacillary or multibacillary disease.
Copyright © 2011 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Keywords:  Baciloscopia; Disability; Discapacidad; Enfermedad de Hansen; Hansen disease; Lepra; Leprosy; M. leprae; Multibacilar; Multibacillary; Multidrug therapy; Multiterapia; Mycobacteria leprae; Paucibacilar; Paucibacillary; Smear test

Mesh:

Substances:

Year:  2013        PMID: 23870850     DOI: 10.1016/j.adengl.2012.03.028

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  33 in total

1.  Comparison of Enzyme-Linked Immunosorbent Assay Using Either Natural Octyl Disaccharide-Leprosy IDRI Diagnostic or Phenolic Glycolipid-I Antigens for the Detection of Leprosy Patients in Colombia.

Authors:  Mónica Muñoz; Juan Camilo Beltrán-Alzate; Malcolm S Duthie; Héctor Serrano-Coll; Nora Cardona-Castro
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  Case Report: Nasal Myiasis in an Elderly Patient with Atrophic Rhinitis and Facial Sequelae of Leprosy.

Authors:  Rachel Azevedo Serafim; Rachel Bertolani do Espírito Santo; Ricardo Andrade Fernandes de Mello; Simon M Collin; Patrícia Duarte Deps
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

3.  Lupus and leprosy: beyond the coincidence.

Authors:  F M Ribeiro; V E Gomez; E M N Albuquerque; E M Klumb; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  Peripheral neuropathy in leprosy: Clinical manifestations and disability in a Colombian national referral center.

Authors:  Laura Trujillo-Ramirez; María Alejandra Palacios-Ariza; Ivan Pradilla; Luis Arturo Gamboa
Journal:  Dermatol Reports       Date:  2021-08-05

5.  Associated factors study into the belated screening for leprosy in Benin.

Authors:  Ronald Sètondji Gnimavo; Ghislain Emmanuel Sopoh; Parfait Djossou; Esaï Gimatal Anagonou; Gilbert Adjimon Ayélo; Anita Carolle Akpéédjé Wadagni; Yves Thierry Barogui; Jean Gabin Houezo; Roch Christian Johnson
Journal:  PLoS Negl Trop Dis       Date:  2022-06-23

6.  Case Report: Leprosy Osteoarticular Alterations Mimicking Rheumatoid Arthritis.

Authors:  Rachel Bertolani do Espírito Santo; Rachel A Serafim; Jurama Barros Gueiros Bitran; Simon M Collin; Patrícia Deps
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

7.  Type I Lepra Reaction as the Presenting Sign of Histoid Leprosy.

Authors:  Jingru Sun; Ping Tu; Shengguo Yi; Wenjing Fu; Yang Wang
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

8.  Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.

Authors:  Alexandre Cc Vieira; Luíse L Chaves; Marina Pinheiro; Domingos Ferreira; Bruno Sarmento; Salette Reis
Journal:  Int J Nanomedicine       Date:  2016-06-03

9.  Epidemiology of Leprosy in Iran from 2005 to 2015.

Authors:  Kamyar Mansori; Erfan Ayubi; Mahshid Nasehi; Shiva Mansouri Hanis; Behzad Amiri; Salman Khazaei
Journal:  Tanaffos       Date:  2017

10.  ELISA-based assay of immunoglobulin G antibodies against mammalian cell entry 1A (Mce1A) protein: a novel diagnostic approach for leprosy.

Authors:  Filipe R Lima; Iukary Takenami; Maurílio Al Cavalcanti; Lee W Riley; Sérgio Arruda
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-12       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.